GILEAD SCIENCES INC Insider Trading for September 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for September 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 23.60 | 70,000 | 1,652,000 | 68,400 | |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 111.56 | 11,802 | 1,316,616 | 165,168 | 177 K to 165.2 K (-6.67 %) |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 110.92 | 41,153 | 4,564,501 | 176,970 | 218.1 K to 177 K (-18.87 %) |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 109.60 | 17,045 | 1,868,077 | 218,123 | 235.2 K to 218.1 K (-7.25 %) |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 23.60 | 70,000 | 1,652,000 | 235,168 | 165.2 K to 235.2 K (+42.38 %) |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Aff ... | Option Exercise | M | 24.30 | 5,000 | 121,475 | 143,742 | |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Aff ... | Sell | S | 110.00 | 5,000 | 550,000 | 135,422 | 140.4 K to 135.4 K (-3.56 %) |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Aff ... | Buy | M | 24.30 | 5,000 | 121,475 | 140,422 | 135.4 K to 140.4 K (+3.69 %) |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 20.71 | 15,000 | 310,575 | 60,000 | |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 110.00 | 15,000 | 1,650,000 | 44,309 | 59.3 K to 44.3 K (-25.29 %) |
| Sep 17 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 20.71 | 15,000 | 310,575 | 59,309 | 44.3 K to 59.3 K (+33.85 %) |
| Sep 10 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 14.50 | 100,000 | 1,450,250 | 300,000 | |
| Sep 10 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 103.39 | 100,000 | 10,338,730 | 1,029,108 | 1.1 M to 1 M (-8.86 %) |
| Sep 10 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 14.50 | 100,000 | 1,450,250 | 1,129,108 | 1 M to 1.1 M (+9.72 %) |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 103.41 | 100 | 10,341 | 94,296 | 94.4 K to 94.3 K (-0.11 %) |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 102.60 | 3,150 | 323,176 | 94,396 | 97.5 K to 94.4 K (-3.23 %) |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 101.75 | 3,000 | 305,261 | 97,546 | 100.5 K to 97.5 K (-2.98 %) |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 24.30 | 8,625 | 209,544 | 148,742 | |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 23.76 | 1,375 | 32,663 | 0 | |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 104.11 | 600 | 62,467 | 135,422 | 136 K to 135.4 K (-0.44 %) |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 103.49 | 3,495 | 361,705 | 136,022 | 139.5 K to 136 K (-2.51 %) |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 102.32 | 7,905 | 808,836 | 139,517 | 147.4 K to 139.5 K (-5.36 %) |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 23.76 | 1,375 | 32,663 | 147,422 | 146 K to 147.4 K (+0.94 %) |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 24.30 | 8,625 | 209,544 | 146,047 | 137.4 K to 146 K (+6.28 %) |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 14.50 | 150,000 | 2,175,375 | 450,000 | |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 104.45 | 1,500 | 156,669 | 3,948,066 | 3.9 M to 3.9 M (-0.04 %) |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 103.64 | 51,672 | 5,355,209 | 3,949,566 | 4 M to 3.9 M (-1.29 %) |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 102.67 | 45,844 | 4,706,959 | 4,001,238 | 4 M to 4 M (-1.13 %) |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 101.81 | 50,984 | 5,190,773 | 4,047,082 | 4.1 M to 4 M (-1.24 %) |
| Sep 03 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 14.50 | 150,000 | 2,175,375 | 4,098,066 | 3.9 M to 4.1 M (+3.80 %) |